Wilson Sonsini - ECP

insight detail

Wilson Sonsini Advises Octant on $80 Million Series B and Partnership with Bristol Myers Squibb

  • 04/21/22
  • Client Highlights
  • Life Sciences
  • Biotech

ECP Attorneys:

Copyright © 2022 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.